0.20
+0.0027(+1.39%)
Currency In USD
Address
2403 Sidney Street
Pittsburgh, PA 15203
United States of America
Phone
412 894 8248
Website
Sector
Healthcare
Industry
Biotechnology
Employees
9
First IPO Date
September 23, 2021
| Name | Title | Pay | Year Born |
| Mr. Rajiv Sarman Shukla | Chief Executive Officer & Executive Chairman | 292,188 | 1975 |
| Mr. Bryan J. Cassaday | Chief Financial Officer | 261,704 | 1969 |
| Dr. Phil Campbell Ph.D. | Founder and Chief Scientific Officer | 0 | N/A |
| Dr. Lee Weiss Ph.D. | Founder | 0 | N/A |
| Dr. James Burgess M.D. | Founder | 0 | N/A |
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.